Physician profile

Michael Y Han

Orthopaedic Surgery · Sacramento, CA

NPI 1144365529

$11,500.37

in general payments reported to CMS, 2019-2025

10 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Travel and Lodging$203.66
Food and Beverage$18.03

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Sequoia Surgical, INC. $8,145.94 2019-2022
Evolution Surgical, INC $1,250.53 2022-2024
Skeletal Dynamics INC $729.35 2021
Stryker Corporation $601.46 2020
Vertex Pharmaceuticals Incorporated $416.67 2019
Intuitive Surgical, INC. $203.66 2024
Smith+Nephew, INC. $84.52 2019-2022
Depuy Synthes Sales INC. $32.87 2019
Avanos Medical $19.77 2019
Bard Access Systems, INC. $15.60 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Michael Y Han

$11,500.37

in general payments reported 2019-2025

Years
2019-2024
Top company
Sequoia Surgical, INC.

https://glasscript.com/doctor/324451/michael-y-han

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.